Biotech

Latest Articles

Cassava pays for $40M over apparently deceptive Alzheimer's improve

.Cassava Sciences has actually agreed to pay for $40 thousand to fix an examination in to claims it ...

Merck bags alternatives on Evaxion's AI-designed injection prospects

.Merck &amp Co. has picked up options on two Evaxion Biotech vaccination prospects, paying $3.2 mill...

Enanta's RSV antiviral crushes virus-like bunch in difficulty research study

.Enanta Pharmaceuticals has connected its breathing syncytial infection (RSV) antiviral to significa...

Biogen cans SAGE-324 collaboration after vital tremor stop working

.Biogen has actually conducted the last rites to its own cooperation along with Sage Therapeutics on...

AbbVie Parkinson's medicine from $8.7 B Cerevel buyout scores

.On the exact same time that some Parkinson's condition medications are actually being actually brou...

Arch closes $3B-plus fund to nurture biopharma upstarts

.On the heels of a $3 billion fund coming from Bain Funds Lifestyle Sciences, Arch Venture Allies is...

Orion to utilize Aitia's 'electronic identical twins' to discover brand-new cancer medications

.Finnish biotech Orion has actually spied potential in Aitia's "digital twin" technician to create n...

Windtree's surprise med increases blood pressure in latest period 2 win

.While Windtree Rehabs has actually strained to grow the economic roots needed to survive, a phase 2...

2 cancer biotechs combine, creating global footprint

.OncoC4 is actually taking AcroImmune-- as well as its own internal clinical manufacturing abilities...

Amgen documents very first phase 3 gain for $400M dermatitis drug

.Amgen has shared (PDF) the 1st period 3 data on its own $400 thousand eczema drug, linking the anti...

Biogen, UCB report period 3 lupus win after neglecting earlier test

.Biogen and also UCB's gamble on advancing right into stage 3 astride a failed research study seeks ...

Aptadir wishes brand-new RNA preventions can turn around complicated cancers cells

.Italian biotech Aptadir Therapies has launched along with the assurance that its pipe of preclinica...

Wave surfs DMD success to regulatory authorities' doors, sending out stock up

.Wave Lifestyle Sciences has met its own goal in a Duchenne muscular dystrophy (DMD) research, placi...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma crease...

Achilles splashes tissue therapy course, bandages for cutbacks after overlooking 'commercial practicality' goals

.Achilles Therapies has actually wrecked its own strategy. The English biotech is actually knocking ...

Aligos trumpets phase 2 MASH succeed, slashing liver fat up to 46%

.Aligos Therapeutics is actually proclaiming a midstage succeed in metabolic-dysfunction linked stea...

Basilea credit ratings $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job cultivating new antifungals has acquired a significant boost from the U...

Capricor markets Europe legal rights to late-stage DMD treatment for $35M

.Having already scooped up the united state rights to Capricor Therapies' late-stage Duchenne muscle...

FDA junks adcomm for Applied's unusual illness medication

.After pushing the selection date for Applied Rehabs' metabolic disorder medicine govorestat, the FD...

Novo inks $600M NanoVation offer to examine hereditary medicines ex-liver

.Novo Nordisk is continuing its own push into genetic medications, accepting pay NanoVation Therapie...